These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7914409)

  • 1. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs.
    Hayllar J; Smith T; Macpherson A; Price AB; Gumpel M; Bjarnason I
    Arthritis Rheum; 1994 Aug; 37(8):1146-50. PubMed ID: 7914409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs.
    Bjarnason I; Zanelli G; Prouse P; Smethurst P; Smith T; Levi S; Gumpel MJ; Levi AJ
    Lancet; 1987 Sep; 2(8561):711-4. PubMed ID: 2888943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal antiinflammatory drug-induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritis.
    Davies NM; Jamali F; Skeith KJ
    Arthritis Rheum; 1996 Feb; 39(2):321-4. PubMed ID: 8849386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of non-steroidal anti-inflammatory drug induced enteropathy.
    Bjarnason I; Hopkinson N; Zanelli G; Prouse P; Smethurst P; Gumpel JM; Levi AJ
    Gut; 1990 Jul; 31(7):777-80. PubMed ID: 1973396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.
    MacMullan PA; Madigan AM; Paul N; Peace AJ; Alagha A; Nolan KB; McCarthy GM; Kenny D
    Clin Rheumatol; 2016 Feb; 35(2):447-55. PubMed ID: 25253538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative toxicity of alternative therapies for rheumatoid arthritis: implications for the therapeutic progression.
    Fries JF; Williams CA; Ramey DR; Bloch DA
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):68-73. PubMed ID: 8278821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.
    Bjarnason I; Zanelli G; Smith T; Prouse P; Williams P; Smethurst P; Delacey G; Gumpel MJ; Levi AJ
    Gastroenterology; 1987 Sep; 93(3):480-9. PubMed ID: 3609658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple strictures of the small intestine after long-term nonsteroidal anti-inflammatory drug therapy.
    Matsuhashi N; Yamada A; Hiraishi M; Konishi T; Minota S; Saito T; Sugano K; Yazaki Y; Mori M; Shiga J
    Am J Gastroenterol; 1992 Sep; 87(9):1183-6. PubMed ID: 1519577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erosive enteropathy in a patient with polyarthritis].
    Bogas M; Afonso Mdo C; Araújo D
    Acta Reumatol Port; 2006; 31(4):349-54. PubMed ID: 17334047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying antirheumatic drugs. Potential effects in older patients.
    Gardner G; Furst DE
    Drugs Aging; 1995 Dec; 7(6):420-37. PubMed ID: 8601050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.
    Sparks JA; Krumme AA; Shrank WH; Matlin OS; Brill G; Pezalla EJ; Choudhry NK; Solomon DH
    Arthritis Rheumatol; 2016 Jul; 68(7):1588-95. PubMed ID: 26866506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rheumatoid arthritis.
    Gaffo A; Saag KG; Curtis JR
    Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of the conventional drugs in the treatment of rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003; 94(7-8):330-8. PubMed ID: 12868241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
    Taha AS; Capell HA; Sturrock RD; Russell RI
    Am J Gastroenterol; 1991 Nov; 86(11):1588-91. PubMed ID: 1683150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.